Graf Akcie SBRA (Sabra Healthcare REIT Inc). Diskuze k akciím SBRA. Aktuální informace SBRA.

Základní informace o společnosti Sabra Healthcare REIT Inc (Akcie SBRA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 3.2B
Hodnota podniku (EV) 5.61B
Tržby 600.603M
EBITDA 254.892M
Zisk -25.55
Růst v tržbách Q/Q -0.64 %
Růst v tržbách Y/Y -1.36 %
P/E (Cena vůči ziskům) N/A
Forward P/E 0.37
EV/Sales 9.34
EV/EBITDA 22.01
EV/EBIT 76.81
PEG 2.36
Price/Sales 5.32
P/FCF 14.14
Price/Book 0.94
Účetní hodnota na akcii 16.00
Hotovost na akcii 0.31
FCF vůči ceně 7.07 %
Počet zaměstnanců 38
Tržba na zaměstnance 15805000
Profit margin 23.12 %
Operating margin 41.50 %
Gross margin 100.00 %
EBIT margin 12.16 %
EBITDA margin 42.44 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -535.71 %
EPS - Očekávaný růst příští rok -5.56 %
Return on assets -0.43 %
Return on equity -0.75 %
ROIC 3.97 %
ROCE 1.25 %
Dluhy/Equity 0.76
Čistý dluh/EBITDA 35.83
Current ratio 2.67
Quick Ratio 2.23
Volatilita 2.46
Beta 1.21
RSI 42.86
Cílová cena analytiků 16
Známka akcie (dle analytiků) 2.64
Insider ownership 1.19 %
Institutional ownership 90.54 %
Počet akcií 220.824M
Procento shortovaných akcií 2.48 %
Short ratio 2.20 %
Dividenda 1.20
Procentuální dividenda 8.04 %
Dividenda/Zisk 181.82 %
Obchodovaná od 2010
Země United States

Finanční výsledky akcie SBRA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$598.569$661.736$623.409$408.281$260.526$238.864
Cost Of Goods Sold------
Gross Profit$598.569$661.736$623.409$408.281$260.526$238.864
Research And Development Expenses------
SG&A Expenses$32.755$30.886$37.094$32.401$17.672$16.093
Other Operating Income Or Expenses$-137.411$-231.529$-90.034$-36.299$-41.057$-15.418
Operating Expenses$346.903$443.964$318.507$212.837$128.398$101.613
Operating Income$251.666$217.772$304.902$195.444$132.128$137.251
Total Non-Operating Income/Expense$-95.94$-138.556$-17.345$-36.428$-60.874$-57.119
Pre-Tax Income$155.726$79.216$287.557$159.016$71.254$80.132
Income Taxes$0.71$3.402$3.011$0.651$1.049$0.749
Income After Taxes$155.016$75.814$284.546$158.365$70.205$79.383
Other Income------
Income From Continuous Operations$138.417$69.018$279.115$158.365$70.205$79.383
Income From Discontinued Operations------
Net Income$138.417$68.996$269.314$148.141$60.034$69.171
EBITDA$428.403$399.321$496.281$309.326$200.6$200.33
EBIT$251.666$217.772$304.902$195.444$132.128$137.251
Basic Shares Outstanding2061871781066562
Shares Outstanding2071881791066662
Basic EPS$0.67$0.37$1.51$1.40$0.92$1.11
EPS - Earnings Per Share$0.67$0.37$1.51$1.40$0.92$1.11
# 2020 2019 2018 2017 2016 2015
Current Ratio------
Long-term Debt / Capital0.41030.40780.49820.49690.54380.567
Debt/Equity Ratio0.69590.68860.9930.98761.19211.3092
Gross Margin------
Operating Margin42.044632.909248.908847.8750.715957.4599
EBIT Margin42.044632.909248.908847.8750.715957.4599
EBITDA Margin71.571260.344579.607675.76376.998183.8678
Pre-Tax Profit Margin26.016411.970946.126538.947727.350133.5471
Net Profit Margin23.124710.426543.200236.284123.043428.9583
Asset Turnover0.10.1090.09350.05810.1150.0968
Inventory Turnover Ratio------
Receiveable Turnover------
Days Sales In Receivables------
ROE - Return On Equity4.06011.97858.57564.60746.9137.5329
Return On Tangible Equity4.16112.03788.93554.84287.0967.5325
ROA - Return On Assets2.31251.13724.18762.2523.09833.2154
ROI - Return On Investment2.39411.17174.30282.31813.15353.2619
Book Value Per Share16.191216.999618.253619.282715.556316.1682
Operating Cash Flow Per Share-0.2677-0.03770.7347-1.40220.74630.1189
Free Cash Flow Per Share-2.21640.77053.9089-3.15216.89179.0128